Evidence map›Paper›PMID 40453164›Full record

ArticleBrazilian journal of veterinary medicine2025

Retrospective five-year study of equine casuistry in a Colombian perinatology center.

Melissa Tovar Parra, Martha Susana Franco Ayala

Abstract read
In one paragraph

Article in Brazilian journal of veterinary medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Melissa Tovar ParraUniversidad de los Andes, Bogotá, Colombia.ORCID 0009-0006-6558-5320
Martha Susana Franco AyalaUniversidad Nacional de Colombia, Programa de Doctorado en Salud Animal, Bogotá, Colombia.ORCID 0000-0001-5261-4694

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A retrospective study was conducted at the Foal Care Equine Perinatology Center in Colombia from October 2017 to May 2023. The goal was to analyze the most frequent pathologies, as well as assess the sexes, ages, and breeds of the patients, with an emphasis on the perinatal population. Out of 945 clinical histories, 776 pertained to perinatology. Survival rates were calculated, and a descriptive analysis was performed. The overall survival rate for neonates was 73.6%, with females constituting 57% of the neonatal patients. The most prevalent breed among mares and neonates was the Creole Colombian Horse. Neonatal maladjustment accounted for 39.34% of the neonatal cases, and regarding the affected systems, there was a common multisystemic presentation (71.40%). Of the 341 foals admitted for neonatal adaptation, 72 were clones (with a survival rate of 76.39%), while 269 were non-clones (with a survival rate of 72.49%). A total of 202 mares (88.98%) were hospitalized for pregnancy monitoring, while 25 mares (11.02%) were brought to the perinatology center to treat dystocia or other reproductive pathologies. The most frequent diagnosis among mares was placentitis (73.68%). This study noted an increase in survival rates over time, which was associated with improvements in protocols and the acquisition of new medical equipment. The survival rates observed in this study are consistent with those reported in previous research. The collected data indicate that foaling occurs year-round in Colombia since the country experiences no distinct seasons. Studies with larger sample sizes are suggested, as well as periodical analysis of casuistry in the equine neonatology field, to improve the clinical management of patients and enhance productivity in the horse breeding industry.

Indexed as

foalneonatepathologiesprognosissurvival

Identifiers

PMID40453164
PMCPMC12124761

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.